Skip to main content

Table 4 The PK/PD target attainment in the course of therapy with meropenem of patients with or without fluid overload on day 1

From: Impact of cumulative fluid balance on the pharmacokinetics of extended infusion meropenem in critically ill patients with sepsis

Characteristics

Day

Fluid overload

No fluid overload

f Cmin > 2 mg/L (%)a

1–3

98 (89–100)

93 (80–98)

f Cmin > 8 mg/L (%)a

1–3

67 (52–80)

27 (20–48)***

%f T > 2 mg/L (%)b

1

99 (2.3)

99 (2.7)

 

2

100 (0.1)

98 (1.6)

 

3

99 (1.2)

100 (0.1)

%f T > 8 mg/L (%)b

1

79 (17)#,3

58 (17)#

 

2

78 (23)#

56 (13)#

 

3

68 (21)#,1

58 (12)#

  1. a the point estimate (95-% confidence interval) of the percent proportion, b the mean (standard deviation), *** p < 0.001 Fisher's exact test.; the results of the Tukey–Kramer multiple-comparison test (α = 0.05): upper numbers indicate within-group differences between the monitoring days 1, 2 and 3; # the between-group difference at the particular day.; abbreviations: fCmin > MIC the proportion of the assayed minimum concentrations of meropenem exceeding the targets of 2 mg/L and 8 mg/L; %f T > MIC the fraction time on the days 1, 2 and 3 with the concentration of meropenem exceeding the targets of 2 mg/L and 8 mg/L